[{"Assets_0_Q1_USD":188491000.0,"CommonStockSharesOutstanding_0_Q1_shares":110840873.0,"EarningsPerShareBasic_1_Q1_USD":0.04,"EarningsPerShareDiluted_1_Q1_USD":0.04,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":10640000.0,"NetIncomeLoss_1_Q1_USD":4327000.0,"StockholdersEquity_0_Q1_USD":129036000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":113730591.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":105708526.0,"Ticker":"MDXG","CIK":"1376339","name":"MIMEDX GROUP, INC.","OfficialName":"MiMedx Group Inc Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"515730569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170501"}]